Bioactivity of a peptide derived from acetylcholinesterase: involvement of an ivermectin-sensitive site on the alpha 7 nicotinic receptor
- 30 June 2004
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 16 (1), 283-289
- https://doi.org/10.1016/j.nbd.2004.02.009
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Ivermectin, an Unconventional Agonist of the Glycine Receptor Chloride ChannelJournal of Biological Chemistry, 2001
- Expression of nicotinic acetylcholine receptors in Alzheimer’s disease: postmortem investigations and experimental approachesBehavioural Brain Research, 2000
- Neurotoxicity of acetylcholinesterase amyloid β‐peptide aggregates is dependent on the type of Aβ peptide and the AChE concentration present in the complexesFEBS Letters, 1999
- Involvement of the NMDA Receptor in a Non–cholinergic Action of Acetylcholinesterase in Guinea–pig Substantia Nigra Pars Compacta NeuronsEuropean Journal of Neuroscience, 1996
- β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampusNeuroReport, 1995
- Structural modifications associated with synaptic development in area CA1 of rat hippocampal organotypic culturesDevelopmental Brain Research, 1993
- The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowthNeuron, 1992
- Cellular and connective organization of slice cultures of the rat hippocampus and fascia dentataJournal of Comparative Neurology, 1984
- ALZHEIMER'S DISEASE AND ACETYLCHOLINESTERASE-CONTAINING NEURONSThe Lancet, 1984
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981